Blueprint Ashwagandha + Rhodiola puts two of the best known adaptogens in one morning capsule, and the two halves of its label could not be easier or harder to judge. The rhodiola half is specified so completely that a buyer can check it against the research line by line, down to the milligram of active compounds. The ashwagandha half prints a dose and nothing else: no extract strength, no percentage of the compounds the trials are built on. Whether the headline ingredient in this capsule matches the studied doses or falls well short of them depends entirely on a number that appears nowhere on the label, the product page, or the brand’s help center.
This is a label breakdown, not a review. Everything below comes from Blueprint’s published Supplement Facts panel and product page, checked against the extracts and doses used in the published trials.
The short version: One veggie capsule provides 300 mg of Rhodiola rosea root extract standardized to 3% rosavins and 1% salidroside, with the panel printing 9 mg of total rosavins, plus 120 mg of ashwagandha root and leaves extract with no standardization stated. The bottle holds 30 capsules and costs $24 as of October 2026, which at 80 cents a day makes it the cheapest daily product in the Blueprint line. It sits in no stack, and the brand suggests pairing it with Essential Capsules.
New to Blueprint? A Blueprint referral link takes $50 off your first order, no code needed. On a $24 bottle, that credit covers the bottle twice over.
The Biggest Trap: Judging the Ashwagandha by Its Milligrams
A buyer comparing ashwagandha products will quickly find the famous trial doses: 300 mg twice a day for the most studied root extract. Set against that, 120 mg looks like a token amount, and the instinct is to call it underdosed and move on. That instinct is wrong, but not in the way the brand would want. Milligrams alone cannot rank an ashwagandha extract, because the studied extracts differ wildly in concentration. Root and leaf extracts, the family this product belongs to, are deliberately concentrated and are trialed at low milligram amounts precisely because each milligram carries more of the active compounds, called withanolides. One respected root and leaf extract was studied for sleep at exactly 120 mg a day.
So the honest problem with this label is not the 120. It is that Blueprint prints no withanolide percentage anywhere, and without it the 120 mg cannot be placed on the map at all. At a weak 2.5% concentration it would deliver about 3 mg of withanolides. At 10% it would deliver 12 mg, in line with the low end of the root and leaf trials. At 35% it would deliver 42 mg, more than the classic root extract trials provided. The brand’s product page promises “precision doses backed by research” and “no pixie dusting” in the same breath. For the rhodiola, it prints the figures that prove it. For the ashwagandha, the figure that would prove it is missing.
The Full Ingredient List, With Doses
Amounts are per serving of one veggie capsule, as printed on the current Supplement Facts panel. The bottle holds 30 servings, taken in the morning with food.
| Ingredient | Amount per serving | Standardization |
|---|---|---|
| Rhodiola rosea root extract | 300 mg | 3% rosavins, 1% salidroside |
| Total rosavins | 9 mg | From the rhodiola extract |
| Ashwagandha root and leaves extract | 120 mg | Not stated on the label |
The Other Ingredients are the capsule and its flow system: hypromellose for the veggie capsule, plus starch, rice extract, rice hulls, gum arabic, and sunflower oil. There are no other botanicals, no caffeine, and nothing else active in the capsule. Daily values are not established for either extract, which is normal for botanicals.
The Rhodiola: The Half You Can Fully Check
Rhodiola rosea is a root extract used for stress related fatigue and mental performance, and its research tradition is unusually specific about what the extract should be. The classic trials used an extract standardized to 3% rosavins and 1% salidroside, at daily doses in the few hundred milligram range. That is exactly what this panel prints: 300 mg at 3% and 1%, with the arithmetic done for the reader in a separate line, 9 mg of total rosavins per capsule.
This matters because rhodiola products vary enormously. Some are standardized only to salidroside, some to rosavins at other ratios, and some print neither, which leaves the buyer comparing raw milligrams of extracts that may share little chemistry. Here the comparison takes ten seconds: same standardization as the trial extracts, a dose inside the studied range, and the delivered rosavins stated outright. Whatever questions the ashwagandha half raises, the rhodiola half is a model of how a botanical label should read.
The Ashwagandha: A Studied Dose, If the Extract Is
Ashwagandha, Withania somnifera, is the stress and sleep herb of the pair, and its evidence base is built on named extracts with known concentrations. The three worth knowing are:
- KSM-66, a root only extract standardized to at least 5% withanolides, trialed at 250 to 600 mg a day. Its best known stress trial gave 300 mg twice a day for 60 days and reduced cortisol by about 28%, against about 8% on placebo.
- Sensoril, a root and leaf extract standardized to at least 10% withanolide glycosides, trialed at 125 to 250 mg a day.
- Shoden, a root and leaf extract standardized to 35% withanolide glycosides, trialed at 120 to 240 mg a day, including the sleep trial run at 120 mg.
Blueprint’s extract is root and leaves, like the second and third of those, and its 120 mg sits at the bottom of the root and leaf trial range by weight. If its concentration resembles theirs, the dose is a real one. If it is a plain extract at the 1.5 to 2.5% withanolides typical of unbranded material, it delivers a small fraction of what any of those trials gave. The label, the product page, and the brand’s own help article all repeat the 120 mg and none of them states a concentration, so the question a buyer most needs answered is the one the brand does not answer. That is a strange gap in a catalog whose other labels print everything, and it is worth naming plainly: on this product, the transparency the brand is known for stops at its headline ingredient.
A Short Safety Note
Ashwagandha is not a take forever and forget herb, and the federal evidence summary is worth reading before any adaptogen purchase. The National Center for Complementary and Integrative Health, part of the National Institutes of Health, summarizes the position in its ashwagandha fact page: the herb appears reasonably safe in the short term, up to about three months, while long term safety is not established; rare cases of liver injury have been reported; it should be avoided during pregnancy; and caution applies for people with thyroid or autoimmune conditions and for people taking sedatives or immunosuppressants. Blueprint’s own guidance fits inside that window, since its help pages describe the product as safe for daily use with an optional cycle of six to eight weeks followed by a break. Rhodiola has a thinner evidence file than ashwagandha overall, which the same agency notes, and its record in short trials is generally uneventful at label doses.
Where It Fits: The Cheapest Add On in the Line
Ashwagandha + Rhodiola appears in none of the three stacks, as the compositions in Blueprint Stacks Explained show. It is a standalone add on at $24 for 30 capsules as of October 2026, with autoship at $22.80, which works out to 80 cents a day at list price. Nothing else in the daily line costs less per day; the next cheapest, the collagen powder, costs nearly twice that. The brand’s suggested routine is one capsule in the morning with food, paired with Blueprint Essential Capsules for the rest of the daily foundation.
If you decide the label earns a try, you can get $50 off your first Blueprint order through a referral link. The credit applies automatically at checkout, no code needed.
Testing: What Can Be Checked
Blueprint states this product is third party tested for purity and heavy metals, and its product pages describe published test results as a general brand practice, citing a JAMA Network Open study that found most herbal supplements in its sample mislabeled. I could not locate a public batch report with measured values for this specific product, so there are no figures to quote here. For a two botanical product, the testing that matters most is identity and potency confirmation of the extracts, which is also, as the ashwagandha section above shows, the area where this label gives the buyer the least to work with. I explained how Blueprint’s published reports work, and how to read one, in Blueprint Third Party Testing.
What Is Not in Blueprint Ashwagandha + Rhodiola
- No caffeine or stimulants. The morning timing comes from the rhodiola’s energizing reputation, not from any stimulant in the capsule.
- No L-theanine. Many adaptogen blends pair the calming amino acid with these two herbs. This formula keeps the two botanicals only.
- No third adaptogen. No ginseng, no cordyceps, no reishi. Two extracts, fully listed, is the whole formula.
- No animal ingredients. The capsule is hypromellose, and the formula is plant based throughout.
What to Look For on Any Adaptogen Label
- A standardization percentage for every botanical, naming the marker compounds. Without it, the milligram dose cannot be compared to any trial.
- The plant part and extract type, root only versus root and leaf, because the studied doses for each family are different.
- The delivered amount of the marker compounds where the brand can state it, the way this label prints 9 mg of total rosavins.
- A serving size of one capsule rather than three, where the doses allow it, since serving games are how weak formulas hide.
- Third party testing for identity, potency, and heavy metals, stated for the product rather than the brand in general.
Frequently Asked Questions
How much ashwagandha is in Blueprint Ashwagandha + Rhodiola?
Each capsule contains 120 mg of ashwagandha root and leaves extract. The label does not state a withanolide percentage, so the amount of active compounds that 120 mg delivers is not published.
Is 120 mg of ashwagandha enough?
It depends entirely on the extract’s concentration, which this label does not disclose. Root and leaf extracts standardized to 10 to 35% withanolides have been trialed at 120 to 250 mg a day, so 120 mg of a concentrated extract is a studied dose. The same weight of a weak extract would deliver far less.
How much rhodiola is in each capsule?
Each capsule contains 300 mg of Rhodiola rosea root extract standardized to 3% rosavins and 1% salidroside, and the panel prints the resulting 9 mg of total rosavins. That standardization matches the extracts used in the classic rhodiola fatigue trials.
When should you take it?
The label directs one capsule in the morning with food. The brand’s help pages add that it can be cycled, for example six to eight weeks of daily use followed by a break, although it describes daily use as acceptable.
Is Ashwagandha + Rhodiola included in any Blueprint stack?
No. It is a standalone product, sold on its own at $24 for a 30 day supply, and the brand suggests combining it with Essential Capsules.
Is it vegan?
Yes. The formula is plant based and the capsule shell is hypromellose rather than gelatin.
The Bottom Line
Blueprint Ashwagandha + Rhodiola is two labels in one capsule. The rhodiola half is exemplary: the classic trial standardization, a dose inside the studied range, and the delivered rosavins printed to the milligram. The ashwagandha half is a dose with its deciding figure missing, from the one brand in this market that built its name on printing every figure. At 80 cents a day the price of finding out is low, and the rhodiola alone is honestly specified. But a buyer who is purchasing this product for the ashwagandha, which the name order suggests most are, should know they are taking its strength on trust.
If you are new, you can get $50 off your first order with this Blueprint referral link.
Related reading: